Related Experiment Videos
The genetic susceptibility to Graves' disease
1Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
Bailliere'S Clinical Endocrinology and Metabolism
|April 9, 1998
Summary
Genetic factors significantly contribute to Graves' disease (GD) development. A newly identified marker near the TSH receptor gene on chromosome 14q31 shows linkage to GD, suggesting a potential gene family involved in endocrine autoimmunity.
Area of Science:
- Endocrinology
- Genetics
- Immunology
Background:
- Graves' disease (GD) is an autoimmune disorder with a significant genetic component.
- Twin and family studies indicate a strong hereditary predisposition to GD.
- Previous research identified HLA-DR3 and CTLA-4 as associated genes, but their contribution is limited.
Purpose of the Study:
- To investigate novel genetic susceptibility loci for Graves' disease.
- To identify additional genes beyond HLA and CTLA-4 involved in GD pathogenesis.
- To explore the genetic architecture of endocrine autoimmunity.
Main Methods:
- Utilized a linkage-based approach to detect highly significant susceptibility genes.
- Analyzed genetic markers in proximity to the TSH receptor gene on chromosome 14q31.
- Examined familial aggregation of Graves' disease and thyroid autoantibodies.
Main Results:
- A specific genetic marker on chromosome 14q31, near the TSH receptor gene, demonstrated linkage to Graves' disease.
- This locus is in the vicinity of the IDDM-11 locus, suggesting potential shared genetic pathways.
- Preliminary findings indicate a potential gene family associated with endocrine autoimmunity on chromosome 14q31.
Conclusions:
- The study provides preliminary evidence for a novel susceptibility gene or gene family for Graves' disease on chromosome 14q31.
- Further research is needed to confirm these findings and elucidate the specific genes involved.
- These results may advance our understanding of the genetic basis of endocrine autoimmune diseases.